Medicare Enrolled

Dr. Miladys Palau Collazo, MD

Pediatric Endocrinology · Port St Lucie, FL
Speaking/Promotional
9401 SW DISCOVERY WAY STE 102, Port St Lucie, FL 34987
7728347362
In practice since 2008 (17 years)
NPI: 1063671212 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Palau Collazo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Palau Collazo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Palau Collazo

Dr. Miladys Palau Collazo is a pediatric endocrinology in Port St Lucie, FL, with 17 years in practice.

Between the years covered by Open Payments, Dr. Palau Collazo received a total of $53,072 from 39 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Palau Collazo is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice$ $53,072 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$53,072
Total received (2018-2024)
Avg $7,582/year across 7 years
Top 5% in FL for pediatric endocrinology
39
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$40,596 (76.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,748 (14.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,728 (8.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,899
2023
$15,318
2022
$5,310
2021
$12,457
2020
$10,963
2019
$561
2018
$564

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$21,576
AbbVie Inc.
$11,937
Medtronic MiniMed, Inc.
$6,930
Zealand Pharma US, Inc.
$5,315
Medtronic, Inc.
$3,244
Novo Nordisk Inc
$595
Insulet Corporation
$342
Ascendis Pharma, Inc.
$337
Ascendis Pharma Inc
$335
Xeris Pharmaceuticals, Inc.
$250
TOLMAR Pharmaceuticals, Inc.
$250
SANOFI-AVENTIS U.S. LLC
$177
BETA BIONICS, INC.
$162
Lilly USA, LLC
$155
ABBVIE INC.
$153
Tandem Diabetes Care, Inc.
$151
Azurity Pharmaceuticals, Inc.
$144
Abbott Laboratories
$102
Tolmar, Inc.
$95
PFIZER INC.
$71
Ultragenyx Pharmaceutical Inc.
$70
Dexcom, Inc.
$67
BioMarin Pharmaceutical Inc.
$58
Kyowa Kirin, Inc.
$54
Endo Pharmaceuticals Inc.
$53
Eton Pharmaceuticals, Inc.
$51
ARBOR PHARMACEUTICALS, INC.
$50
Amphastar Pharmaceuticals, Inc.
$44
DEXCOM, INC.
$40
Arbor Pharmaceuticals, Inc.
$34
Intuity Medical Inc
$31
Ferring Pharmaceuticals Inc.
$29
Neurocrine Biosciences, Inc.
$28
AbbVie, Inc.
$28
Mannkind Corporation
$27
Alnylam Pharmaceuticals Inc.
$25
Amryt Pharma Holdings Ltd
$21
IBSA Pharma Inc.
$21
Companion Medical, Inc.
$20
Top 3 companies account for 76.2% of total payments
Associated products mentioned in payments ›
AFREZZA · ALKINDI · BAQSIMI · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · FENSOLVI · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GENOTROPIN · GVOKE HYPOPEN · GVOKE PFS · INPEN SMART INSULIN DELIVERY SYSTEM · InPen · LUPRON DEPOT · Lupron Depot-PED · MINIMED 780G · Macrilen · Minimed 670G System · Norditropin · OXLUMO · Omnipod · Ozempic · Pogo Automatic Blood Glucose Monitoring System · SKYTROFA · STRENSIQ · SUPPRELIN · Saxenda · Skytrofa · Sogroya · Strensiq · TRIPTODUR · TZIELD · Tirosint · Triptodur · V-GO DISPOSABLE INSULIN DELIVERY · VOXZOGO 1.2mg · Victoza · ZEGALOGUE · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatric endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for pediatric endocrinology in FL.

Looking for a pediatric endocrinology in Port St Lucie?
Compare pediatric endocrinologys in the Port St Lucie area by procedure volume, costs, and industry payment transparency.
Browse pediatric endocrinologys nearby

Geographic Context

Pediatric Endocrinologys within 10 mi
1
Per 100K population
0.3
County median income
$69,027
Nearest hospital
ST LUCIE MEDICAL CENTER
12.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Palau Collazo is a pediatric endocrinology, and high industry engagement (speaking/promotional, top 5%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Palau Collazo receive payments from pharmaceutical companies?
Yes. Dr. Palau Collazo received a total of $53,072 from 39 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Palau Collazo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →